作者的详细信息

Maev, Igor V.

栏目 标题 文件
卷 93, 编号 4 (2021) Reviews Exocrine pancreas insufficiency: clinical significance and approaches to correction from evidence medicine PDF
(Rus)
卷 93, 编号 8 (2021) Editorial Pharmacotherapy of inflammatory bowel diseases: efficacy performance and safety management PDF
(Rus)
卷 93, 编号 8 (2021) Original articles Prevalence and prognostic value of gastroenterological manifestations of COVID-19: data from the Russian University Clinic PDF
(Rus)
卷 93, 编号 8 (2021) Original articles Efficacy of trimebutine in the treatment of functional gastrointestinal disorders: an observational multicenter study PDF
(Rus)
卷 93, 编号 12 (2021) Original articles Complex assessment of esophageal acidification and motor function in patients with Barrett's esophagus on antisecretory therapy PDF
(Rus)
卷 93, 编号 11 (2021) Original articles Efficacy and safety of bulevirtide in patients with chronic hepatitis D and compensated cirrhosis PDF
(Rus)
卷 94, 编号 1 (2022) Original articles Multicenter study of gastroesophageal reflux disease symptoms prevalence in outpatients in Russia PDF
(Rus)
卷 94, 编号 2 (2022) Original articles The effectiveness of eradication therapy of the 1st line of Helicobacter pylori infection in patients with type 2 diabetes mellitus PDF
(Rus)
卷 94, 编号 8 (2022) GUIDELINES Epithelial protective therapy in comorbid diseases. Practical Guidelines for Physicians PDF
(Rus)
卷 94, 编号 8 (2022) Original articles Composition of oropharyngeal microbiota in patients with COVID-19 of different pneumonia severity PDF
(Rus)
卷 94, 编号 8 (2022) Clinical notes Masks hiding mitochondrial neurogastrointestinal encephalomyopathy. Case report PDF
(Rus)
卷 94, 编号 9 (2022) Original articles Prevalence of combination of functional dyspepsia and irritable bowel syndrome: a meta-analysis of studies using the Rome III–IV Criteria PDF
(Rus)
卷 94, 编号 10 (2022) Original articles Efficacy of Saccharomyces boulardii CNCM I-745 probiotic drug in the prevention and treatment of diarrhea in hospitalized patients with new coronavirus infection COVID-19 PDF
(Rus)
卷 94, 编号 11 (2022) Reviews Liver disease during the pandemic of COVID-19 infection: prediction of the course and tactics of management: A review PDF
(Rus)
卷 94, 编号 12 (2022) Original articles Efficacy of esophagus protection in complex treatment of erosive gastroesophageal reflux disease: a systematic review and meta-analysis of controlled trials PDF
(Rus)
卷 94, 编号 12 (2022) Original articles Treatment of toxic hepatitis in COVID-19 patients PDF
(Rus)
卷 95, 编号 1 (2023) Original articles Irritable bowel syndrome in the Russian Federation: results of the ROMERUS multicenter observational study PDF
(Rus)
卷 95, 编号 2 (2023) Original articles Effectiveness of empirical Helicobacter pylori eradication therapy with furazolidone in Russia: results from the European Registry on Helicobacter pylori Management (Hp-EuReg) PDF
(Rus)
卷 95, 编号 2 (2023) Original articles Comparative analysis of the intestinal microbiota in patients with exocrine pancreatic insufficiency of various severity PDF
(Rus)
卷 95, 编号 7 (2023) Reviews Diseases of the gastrointestinal tract in the context of COVID-19 infection: present and future challenges: A review PDF
(Rus)
卷 95, 编号 8 (2023) Editorial Drug-induced liver injury: diagnosis of exclusion PDF
(Rus)
卷 95, 编号 8 (2023) Original articles Assessment of body mass index in patients with chronic hepatitis C who received an effective antiviral therapy PDF
(Rus)
卷 95, 编号 8 (2023) Reviews Current status and prospects of using the prokinetic acotiamide in gastroenterology: A review PDF
(Rus)
卷 95, 编号 12 (2023) Reviews Inflammatory bowel diseases: Transformation of representations. A review PDF
(Rus)
卷 95, 编号 12 (2023) Editorial Study of the resistome of human microbial communities using a targeted panel of antibiotic resistance genes in COVID-19 patients PDF
(Rus)
卷 96, 编号 2 (2024) Consensuns Resolution of the Expert Forum "New therapeutic horizons of NAFLD" PDF
(Rus)

##common.cookie##